Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 5, 2021
Accession Number:
0001193125-21-103349
Submission Type:
POS AM
CIK:
0001807901
Company Name:
Pandion Therapeutics, Inc.
File Number:
333-239894